<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2F165730-D778-4994-9AF6-8223860C676A"><gtr:id>2F165730-D778-4994-9AF6-8223860C676A</gtr:id><gtr:firstName>Bouke</gtr:firstName><gtr:surname>de Jong</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190085850"><gtr:id>D35F9EDD-FA14-44B0-AF1C-D6EE7A2BE3BC</gtr:id><gtr:title>Comparison of expression profiles in sputum between M. africanum and M. tuberculosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190085850</gtr:grantReference><gtr:abstractText>Mycobacterium africanum causes up to half of TB in West Africa. It is closely related to regular M. tuberculosis, but we have identified some important differences. One of these is that a new diagnostic test does not perform well in people infected with M. africanum. This test is based on the protein ESAT-6, which is also used in a new generation TB vaccine. Another difference is that HIV infected people are even more susceptible to infection with M. africanum than with M. tuberculosis. Thirdly, people who were exposed to M. africanum are less likely to develop TB than those exposed to M. tuberculosis.||We now propose to study the bacterial genes in more detail, in an attempt to pinpoint the causes for the differences. Ultimately we hope our findings on genetic differences may assist in optimization of diagnostic tests and perhaps with the design of new vaccine candidates.</gtr:abstractText><gtr:technicalSummary>M. africanum, phylogenetically situated between M. tuberculosis and M. bovis in the M. tuberculosis complex, is an important cause of TB in West-Africa. Within the TB case contact studies, we genotyped isolates using spoligotyping and PCRs for lineage defining Large Sequence Polymorphisms. We correlate these genotypes with the clinical and immunological findings from TB cases and their household contacts (also see SCC 965).||Among 376 clinical isolates, 38% was identified as M. africanum and the rest as M. tuberculosis. Patients infected with M. africanum were more likely to be HIV positive (p=0.024), and more likely to be of Fula ethnicity (p=0.042). There was no difference in clinical or radiological findings between cases diseased with M. africanum relative to M. tuberculosis, and mortality was similar in those who were HIV negative and adherent to treatment (p=0.95). Among the 2495 contacts, transmission of M. africanum was similar to that of M. tuberculosis, as measured by Mantoux skin test (p=0.10). However, similarly to cases, contacts exposed to M. africanum were less likely to generate an IFNgamma response to ESAT-6 than those exposed to M. tuberculosis (p=0.024 for cases and p=0.004 for contacts). In addition, contacts of M. africanum were less likely to progress to disease during the 2 year follow-up (p=0.030).||The current proposal aims to compare the genome and the ex vivo transcriptome of M. africanum relative to M. tuberculosis in order to clarify the genetic underpinnings of these phenotypic differences.||The genomic comparison will be done in collaboration with the Wellcome Trust Sanger Centre which is in the process of sequencing one of our M. africanum isolates. Transcriptome comparisons will be conducted in parallel in collaboration with Stanford University (RT-qPCR for all 1200 operons of M. tuberculosis) and the Max Planck Institute (microarray after RNA-amplification).||So far, we have collected 39 of 60 sputum samples from TB patients directly in RNA fixative and extracted their RNA. Parallel samples are processed for DNA extraction and genotyping. The molecular work will be done by the Principal Investigator in the collaborating laboratories.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>730160</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We developed and optimized an RNA extraction technique for mycobacteria in sputum</gtr:description><gtr:id>3137F449-25B4-46B6-99A0-18B4F85430B2</gtr:id><gtr:impact>Collaborators in Uganda and in China are applying the same technique</gtr:impact><gtr:outcomeId>kJyv1RLxKJd</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>extraction of mycobacterial RNA from clinical samples</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3096AA4E-E138-4A77-8F22-814B46AAD068</gtr:id><gtr:title>The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complex.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed467b9b110c9f187ed7663f41ed5a07"><gtr:id>ed467b9b110c9f187ed7663f41ed5a07</gtr:id><gtr:otherNames>Bentley SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_15731_21_22389744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09E07C5B-88AC-4197-9B8C-6C9CF7A471C6</gtr:id><gtr:title>Impaired fitness of Mycobacterium africanum despite secretion of ESAT-6.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a088c95952bd49bc9d765011a81a12ff"><gtr:id>a088c95952bd49bc9d765011a81a12ff</gtr:id><gtr:otherNames>Bold TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_15731_21_22301632</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190085850</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>